Back to results
US 2026/0256829 A1Published application
Pharmaceutical Preparation Containing Selenite or Selenite-Containing Compounds for Treating Cervical Dysplasia or Carcinomas
AssigneeSelo Medical GmbH
InventorNorbert Fuchs
Life of this patent
Estimating the term…
Abstract
The invention relates to compositions containing selenite-containing compounds and pharmaceutically acceptable acids, selected from citric acid, acetic acid, malic acid, carbonic acid, sulphuric acid, nitric acid, hydrochloric acid, fruit acids or mixtures thereof, for use for treating cervical inflammations, dysplasia and/or carcinomas. The invention further relates to methods of using such compositions.
Claims21
A method comprising:
- obtaining a pharmaceutical composition comprising at least one selenite-containing compound and at least one pharmaceutically acceptable acid, further defined as citric acid, acetic acid, malic acid, carbonic acid, sulfuric acid, nitric acid, hydrochloric acid, or a fruit acid;
- and
- administering the composition to a subject having an inflammation of the cervix, a dysplasia of the cervix, and/or a carcinoma of the cervix;
- wherein the inflammation of the cervix, the dysplasia of the cervix, and/or the carcinoma of the cervix is treated in the subject.
1 more element
A method comprising:
- obtaining a pharmaceutical composition comprising at least one selenite-containing compound and at least one pharmaceutically acceptable acid, further defined as citric acid, acetic acid, malic acid, carbonic acid, sulfuric acid, nitric acid, hydrochloric acid, or a fruit acid;
- and
- administering the composition intravaginally to a subject having an inflammation of the cervix, a dysplasia of the cervix, and/or a carcinoma of the cervix;
- wherein the inflammation of the cervix, the dysplasia of the cervix, and/or the carcinoma of the cervix is treated in the subject;
- and
- wherein administration is discontinued during menstruation of the subject.
3 more elements
A method comprising:
- obtaining a pharmaceutical composition comprising at least one selenite-containing compound and at least one pharmaceutically acceptable acid, further defined as citric acid, acetic acid, malic acid, carbonic acid, sulfuric acid, nitric acid, hydrochloric acid, or a fruit acid;
- and
- administering the composition intravaginally to a subject;
- wherein administration is discontinued during menstruation of the subject.
1 more element
Dependencies are inferred from the claim text.